Cargando…
Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039389/ https://www.ncbi.nlm.nih.gov/pubmed/29367711 http://dx.doi.org/10.1038/s41409-017-0080-6 |
_version_ | 1783338662370476032 |
---|---|
author | Kotchetkov, Rouslan Dyszkiewicz-Korpanty, Anna Kukreti, Vishal |
author_facet | Kotchetkov, Rouslan Dyszkiewicz-Korpanty, Anna Kukreti, Vishal |
author_sort | Kotchetkov, Rouslan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6039389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60393892018-07-12 Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy Kotchetkov, Rouslan Dyszkiewicz-Korpanty, Anna Kukreti, Vishal Bone Marrow Transplant Correspondence Nature Publishing Group UK 2018-01-24 2018 /pmc/articles/PMC6039389/ /pubmed/29367711 http://dx.doi.org/10.1038/s41409-017-0080-6 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. If you remix, transform, or build upon this article or a part thereof, you must distribute your contributions under the same license as the original. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/. |
spellingShingle | Correspondence Kotchetkov, Rouslan Dyszkiewicz-Korpanty, Anna Kukreti, Vishal Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy |
title | Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy |
title_full | Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy |
title_fullStr | Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy |
title_full_unstemmed | Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy |
title_short | Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy |
title_sort | chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039389/ https://www.ncbi.nlm.nih.gov/pubmed/29367711 http://dx.doi.org/10.1038/s41409-017-0080-6 |
work_keys_str_mv | AT kotchetkovrouslan chemotherapywithstemcelltransplantationismoreeffectivethanimmunotherapyinsporadiclateonsetnemalinemyopathywithmonoclonalgammopathy AT dyszkiewiczkorpantyanna chemotherapywithstemcelltransplantationismoreeffectivethanimmunotherapyinsporadiclateonsetnemalinemyopathywithmonoclonalgammopathy AT kukretivishal chemotherapywithstemcelltransplantationismoreeffectivethanimmunotherapyinsporadiclateonsetnemalinemyopathywithmonoclonalgammopathy |